Foxo SPAC Presentation Deck
Implied Valuation
Significant potential for meaningful investor value creation
Applies 1.7x-6.3x EV / revenue multiple to FOXO's 2025E revenue
to arrive at an implied future enterprise value
The range reflects the fact that there is no company perfectly
comparable to FOXO and we are using a broad peer set
Implied future enterprise value is discounted 4 years at an
illustrative 50% rate
FOXO is offered at a 41% discount to a conservatively derived
illustrative enterprise value
HIGH GROWTH DISTRIBUTION
DIAGNOSTICS BIOTECH
INSURTECH
FOXO™
Note: This slide contains projected financial information. Such projected financial information
constitutes forward looking information and is for illustrative purposes only and should not be
relied upon as necessarily being indicative of future results.
FOXO INVESTOR DECK 2022 Page 37
Relative Valuation ($B)
$5.0
$1.4
2025E EV implied by 1.7x-6.3x
revenue of $789M
$1.0
$0.3
2025E Current EV implied by
discounting EV by 50%
discount rate
Transaction Value
Represents 41% discount
to midpoint
$369M EV
FOXO
Note: Valuation utilizes 2023E High Growth Distribution and 2024E Diagnostics Biotech and
Insurtech peer multiples due to lack of sufficient analyst estimates beyond those years.View entire presentation